发明名称 | Use of semaphorin-4D binding molecules for treating neurodegenerative disorders | ||
摘要 | Provided herein are methods for alleviating symptoms in a subject having a neurodegenerative disorder, comprising administering to the subject an effective amount of an isolated binding molecule which specifically binds to semaphorin-4D (SEMA4D) or to its Plexin-B1 or Plexin-B2 receptors. | ||
申请公布号 | US9598495(B2) | 申请公布日期 | 2017.03.21 |
申请号 | US201414519965 | 申请日期 | 2014.10.21 |
申请人 | VACCINEX, INC. | 发明人 | Smith Ernest S.;Zauderer Maurice;Bowers William J.;Jonason Alan |
分类号 | C07K16/28;A61K39/395;A61K45/06;A61K39/00 | 主分类号 | C07K16/28 |
代理机构 | Thompson Coburn LLP | 代理人 | Thompson Coburn LLP |
主权项 | 1. A method of treating a subject having, determined to have, or suspected of having a neurodegenerative disorder, comprising administering to a subject in need of treatment an effective amount of an isolated antibody or antigen-binding fragment thereof that specifically binds to semaphorin-4D (SEMA4D), wherein the antibody or fragment thereof comprises a variable heavy chain (VH) comprising VHCDRs 1-3 comprising SEQ ID NOs 6, 7, and 8, respectively, and a variable light chain (VL) comprising VLCDRs 1-3 comprising SEQ ID NOs 14, 15, and 16, respectively, and wherein the antibody or fragment thereof can prevent or reduce reactive astrogliosis in the subject. | ||
地址 | Rochester NY US |